{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:43:11Z","timestamp":1768560191968,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00c3\u00a7\u00c3\u00a3o de Amparo \u00c3\u00a0 Pesquisa do Estado de S\u00c3\u00a3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00c3\u00a7\u00c3\u00a3o de Aperfei\u00c3\u00a7oamento de Pessoal de N\u00c3\u00advel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.vaccine.2018.07.043","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T08:07:37Z","timestamp":1533370057000},"page":"5609-5616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immune response to a Tdap booster in vertically HIV-infected adolescents"],"prefix":"10.1016","volume":"36","author":[{"given":"Fernanda Garcia","family":"Spina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A\u00edda","family":"Gouvea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina C\u00e9lia de Menezes","family":"Succi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Calanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily Yin","family":"Weckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Terreri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Aparecida Sakauchi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"de Moraes-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.043_b0005","series-title":"Red book: 2015 report of the committee on infectious diseases","first-page":"1","article-title":"Active and passive immunization- prologue","author":"American Academy of Pediatrics","year":"2015"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2018.07.043_b0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1086\/315533","article-title":"The changing epidemiology of diphtheria in the vaccine era","volume":"181","author":"Galazka","year":"2000","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.043_b0015","doi-asserted-by":"crossref","first-page":"30014","DOI":"10.2807\/1560-7917.ES.2016.21.48.30414","article-title":"More than 20 years after re-emerging in the 1990s, diphtheria remains a public health problem in Latvia","volume":"21","author":"Kantsone","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.07.043_b0020","first-page":"283","article-title":"The pertussis enigma: reconciling epidemiology, immunology and evolution","volume":"13","author":"Domenech de Cell\u00e8s","year":"2016","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2018.07.043_b0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamapediatrics.2015.4875","article-title":"Impact of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccinations on reported pertussis cases among those 11 to 18 years of age in an era of waning pertussis immunity: a follow-up analysis","volume":"170","author":"Skoff","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2018.07.043_b0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/archdischild-2014-306079","article-title":"Paediatric HIV grows up: recent advances in perinatally acquired HIV","volume":"100","author":"Bamford","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2018.07.043_b0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0000000000001831","article-title":"Immunity following childhood vaccinations in perinatally HIV-exposed children with and without HIV infection in Latin America","volume":"37","author":"Succi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.043_b0040","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4161\/hv.21827","article-title":"Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions","volume":"8","author":"Cagigi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.07.043_b0045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/INF.0000000000001613","article-title":"Persistence of hepatitis B immunity following 3-dose infant primary series in HIV-infected Thai adolescents and immunologic response to revaccination","volume":"36","author":"Lapphra","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.043_b0050","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/jpids\/piw094","article-title":"Immunogenicity of a booster dose of quadrivalent meningococcal conjugate vaccine in previously immunized HIV-infected children and youth","volume":"6","author":"Warshaw","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2018.07.043_b0055","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/523705","article-title":"Making sense of blips","volume":"196","author":"Gallant","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.043_b0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1699-0463.1997.tb05093.x","article-title":"Improved ELISA for determination of anti-diphtheria and\/or anti-tetanus antitoxin antibodies in sera","volume":"105","author":"Kristiansen","year":"1997","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.vaccine.2018.07.043_b0065","series-title":"The immunological basis for immunization series. Module 3: tetanus","first-page":"1","author":"Borrow","year":"2006"},{"key":"10.1016\/j.vaccine.2018.07.043_b0070","series-title":"The immunological basis for immunization series. Module 2: diphtheria","first-page":"1","author":"Scheifele","year":"2009"},{"key":"10.1016\/j.vaccine.2018.07.043_b0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.043_b0080","series-title":"The immunological basis for immunization series. Module 4: pertussis","first-page":"1","author":"K\u00f6nig","year":"2010"},{"key":"10.1016\/j.vaccine.2018.07.043_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.vaccine.2015.11.049","article-title":"Pertussis specific cell mediated immune responses ten years after acellular pertussis booster vaccination in young adults","volume":"34","author":"Gr\u00f6ndahl-Yli-Hannuksela","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.043_b0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.07.043_b0095","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.it.2014.06.002","article-title":"Phenotype and functions of memory Tfh cells in human blood","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2018.07.043_b0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.043_b0105","doi-asserted-by":"crossref","first-page":"e5094","DOI":"10.1097\/MD.0000000000005094","article-title":"CD4\/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART","volume":"95","author":"Sauter","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.vaccine.2018.07.043_b0110","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.173.3.2184","article-title":"Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy","volume":"173","author":"Elrefaei","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.043_b0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/COH.0b013e32835f9788","article-title":"Immune activation and HIV persistence: considerations for novel therapeutic interventions","volume":"8","author":"Hatano","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2018.07.043_b0120","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/QAD.0000000000001147","article-title":"Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections","volume":"30","author":"B\u00e4chle","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2018.07.043_b0125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/imm.12793","article-title":"Here, there and everywhere: T follicular helper cells on the move","volume":"152","author":"Ma","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2018.07.043_b0130","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.4049\/jimmunol.1501524","article-title":"Reversible reprogramming of circulating memory T follicular helper cell function during chronic HIV infection","volume":"195","author":"Cubas","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.043_b0135","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.4049\/jimmunol.1600143","article-title":"Induction of Th1-biased T follicular helper (Tfh) cells in lymphoid tissues during chronic Simian immunodeficiency virus infection defines functionally distinct germinal center Tfh cells","volume":"197","author":"Velu","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.043_b0140","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.07.043_b0145","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2005.05.016","article-title":"Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection","volume":"116","author":"Rosenblatt","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.07.043_b0150","doi-asserted-by":"crossref","first-page":"e1190","DOI":"10.1542\/peds.2007-0729","article-title":"Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy","volume":"20","author":"Abzug","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.07.043_b0155","series-title":"Vaccine","first-page":"746","article-title":"Tetanus toxoid","author":"Roper","year":"2013"},{"key":"10.1016\/j.vaccine.2018.07.043_b0160","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.vaccine.2014.12.018","article-title":"Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule","volume":"5","author":"Ladhani","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2018.07.043_b0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2013.01.001","article-title":"CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization","volume":"390","author":"Livingston","year":"2013","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2018.07.043_b0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mi.2012.54","article-title":"Immunity to the respiratory pathogen Bordetella pertussis","volume":"5","author":"Higgs","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2018.07.043_b0175","doi-asserted-by":"crossref","first-page":"e1003264","DOI":"10.1371\/journal.ppat.1003264","article-title":"Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine","volume":"9","author":"Ross","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.07.043_b0180","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jis380","article-title":"Interleukin 10 responses are associated with sustained CD4 T-Cell counts in treated HIV infection","volume":"206","author":"Villacres","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.043_b0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cyto.2016.08.010","article-title":"Increased expression of negative regulators of cytokine signaling during chronic HIV disease cause functionally exhausted state of dendritic cells","volume":"91","author":"Sachdeva","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2018.07.043_b0190","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood-2003-07-2314","article-title":"HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation","volume":"104","author":"Smed-S\u00f6rensen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2018.07.043_b0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1473-3099(17)30612-6","article-title":"A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2\/3, randomised controlled non-inferiority trial","volume":"18","author":"Sricharoenchai","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:26Z","timestamp":1759400846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18310120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":39,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0264410X18310120"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune response to a Tdap booster in vertically HIV-infected adolescents","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}